Improving Quality of Life During Chemotherapy: Cannabinoids, Cryotherapy, and Scalp Cooling
American Society of Clinical Oncology Educational Book · 2023
DOI: 10.1200/edbk_390428 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Society of Clinical Oncology Educational Book, 2023. Verfasst von Alissa Michel und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY. Hauptthemen laut MEDLINE: Hypothermia, Induced, Cannabinoids, Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 81 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
There have been significant advances in the treatment of cancer in the past decade. However, patients continue to suffer from significant side effects of antineoplastic agents that greatly affect their quality of life (QOL), including chemotherapy-induced nausea and vomiting (CINV), chemotherapy-induced peripheral neuropathy (CIPN), and chemotherapy-induced alopecia (CIA). This review aims to provide an updated overview of emerging strategies for the management and prevention of these immediate and long-lasting side effects. The use of integrative medicine including cannabis continues to evolve in the realm of CINV and cancer-related anorexia. Although no pharmaceutical agent has been approved for the prevention of CIPN, cryotherapy, compression therapy and, more recently, cryocompression therapy have shown benefit in small trials, but there are concerns with tolerability especially related to cryotherapy. More data are necessary to determine an effective and tolerable option to prevent CIPN in large, randomized studies. Scalp cooling (SC), which has a similar mechanism to cryotherapy and compression therapy for CIPN prevention, has proven to be an effective and tolerable approach in randomized studies and has significantly limited CIA, an entity that definitively affects the QOL of patients living with cancer. Taken together, cannabis, cryotherapy, compression and cryocompression therapy, and SC all strive to improve the QOL of patients living with cancer by minimizing the side effects of chemotherapeutic agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY.
- City of Hope National Medical Center, Duarte, CA.
- Dana-Farber Cancer Institute, Boston, MA.
- Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY.
ORCID-Profile: Melissa K Accordino
Zitieren
APA
Michel, A., Lee, R. T., Salehi, E., & Accordino, M. K. (2023). Improving Quality of Life During Chemotherapy: Cannabinoids, Cryotherapy, and Scalp Cooling. American Society of Clinical Oncology Educational Book. https://doi.org/10.1200/edbk_390428
Vancouver
Michel A, Lee RT, Salehi E, Accordino MK. Improving Quality of Life During Chemotherapy: Cannabinoids, Cryotherapy, and Scalp Cooling. American Society of Clinical Oncology Educational Book. 2023. doi:10.1200/edbk_390428
BibTeX
@article{Michel2023,
author = {Michel, Alissa and Lee, Richard T and Salehi, Elahe and Accordino, Melissa K},
title = {Improving Quality of Life During Chemotherapy: Cannabinoids, Cryotherapy, and Scalp Cooling},
journal = {American Society of Clinical Oncology Educational Book},
year = {2023},
doi = {10.1200/edbk_390428}
}
EUVIMED